Nuvectra Corporation

A New Kind of Medical Device Company. At Nuvectra™, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers.
Type
Public
HQ
Plano, US
Founded
2016
Size (employees)
89 (est)
Nuvectra Corporation was founded in 2016 and is headquartered in Plano, US

Nuvectra Corporation Office Locations

Nuvectra Corporation has an office in Plano
Plano, US (HQ)
1100 5830 Granite Pkwy

Nuvectra Corporation Data and Metrics

Nuvectra Corporation Financial Metrics

Nuvectra Corporation's revenue was reported to be $12.5 m in FY, 2016 which is a 139% increase from the previous period.
USD

Revenue (FY, 2016)

12.5 m

Revenue growth (FY, 2015 - FY, 2016), %

139%

Gross profit (FY, 2016)

6.1 m

Gross profit margin (FY, 2016), %

49%

Net income (FY, 2016)

(38.4 m)

EBIT (FY, 2016)

(37.4 m)

Market capitalization (21-Jul-2017)

126.4 m

Cash (31-Dec-2016)

63.7 m

EV

76.4 m
Nuvectra Corporation's current market capitalization is $126.4 m.
USDFY, 2015FY, 2016

Revenue

5.2 m12.5 m

Revenue growth, %

139%

Cost of goods sold

3.4 m6.4 m

Gross profit

1.9 m6.1 m

Gross profit Margin, %

36%49%

R&D expense

15.4 m14.5 m

General and administrative expense

10.5 m28.5 m

Operating expense total

26.3 m43.5 m

EBIT

(24.4 m)(37.4 m)

EBIT margin, %

(466%)(298%)

Interest expense

1.3 m

Pre tax profit

(24.4 m)(38.4 m)

Net Income

(24.4 m)(38.4 m)
USDFY, 2015FY, 2016

Cash

202 k63.7 m

Accounts Receivable

4.2 m

Inventories

24 k5.2 m

Current Assets

764 k72.6 m

PP&E

4.5 m6.3 m

Goodwill

38.2 m38.2 m

Total Assets

45.4 m119.3 m

Accounts Payable

9.9 m

Total Debt

13.7 m

Current Liabilities

7.6 m16 m

Total Liabilities

7.6 m30.7 m

Additional Paid-in Capital

121.8 m

Retained Earnings

(125.1 m)(33.2 m)

Total Equity

37.8 m88.6 m

Debt to Equity Ratio

0.2 x

Debt to Assets Ratio

0.1 x

Financial Leverage

1.2 x1.3 x
USDFY, 2015FY, 2016

Net Income

(24.4 m)(38.4 m)

Cash From Operating Activities

(23.4 m)(25.8 m)

Purchases of PP&E

(529 k)(4 m)

Cash From Investing Activities

(529 k)(4 m)

Cash From Financing Activities

23.7 m93.3 m
USDY, 2016

EV/EBIT

-2 x

EV/CFO

-3 x

Revenue/Employee

140.8 k

Debt/Equity

0.2 x

Debt/Assets

0.1 x

Financial Leverage

1.3 x

Nuvectra Corporation Operating Metrics

Nuvectra Corporation's Patent Applications was reported to be 132 in FY, 2016
FY, 2016

Trademarks

5

Trademarks (foreign)

17

Trademarks Pending

31

Patent Applications

132

Patents Issued

265

Nuvectra Corporation Market Value History

Nuvectra Corporation Revenue Breakdown

Nuvectra Corporation Company Life and Culture

You may also be interested in